Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Immunology
Volume 2016 (2016), Article ID 4391537, 5 pages
http://dx.doi.org/10.1155/2016/4391537
Case Report

Successful Pregnancy Outcome in Women with Recurrent IVF Failure and Anti-hCG Autoimmunity: A Report of Three Cases

Department of Assisted Reproduction Technologies, FSBI D. O. Ott Research Institute of Obstetrics, Gynecology and Reproductology, Saint Petersburg, Russia

Received 30 July 2016; Accepted 6 November 2016

Academic Editor: Claudio Pignata

Copyright © 2016 Valeria Muller et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Gleicher, A. El-Roeiy, E. Confino, and J. Friberg, “Reproductive failure because of autoantibodies: unexplained infertility and pregnancy wastage,” American Journal of Obstetrics and Gynecology, vol. 160, no. 6, pp. 1376–1385, 1989. View at Publisher · View at Google Scholar · View at Scopus
  2. B. C. Heng, W. Huang, X. Zhong, P. Yin, and G. Q. Tong, “Roles of antiphospholipid antibodies, antithyroid antibodies and antisperm antibodies in female reproductive health,” Integrative Medicine International, vol. 2, no. 1-2, pp. 21–31, 2015. View at Publisher · View at Google Scholar
  3. K. Haller-Kikkatalo, A. Salumets, and R. Uibo, “Review on autoimmune reactions in female infertility: antibodies to follicle stimulating hormone,” Clinical and Developmental Immunology, vol. 2012, Article ID 762541, 15 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Bobak, D. Bobakova, Z. Vaczy, J. Rosocha, and A. Halagovec, “Incidence of antibodies in women after failure of assisted reproduction,” Bratislavske Lekárske Listy, vol. 115, no. 3, pp. 145–149, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. G. P. Talwar, J. C. Gupta, K. N. Nand, R. Thapa, and M. Mehta, “Making of vaccines against human chorionic gonadotrophin for control of fertility of women without impairment of ovulation and menstrual regularity,” Reproductive Immunology: Open Access, vol. 1, no. 1, pp. 1–5, 2016. View at Google Scholar
  6. F. Amato, G. M. Warnes, C. A. Kirby, and R. J. Norman, “Infertility caused by HCG autoantibody,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 3, pp. 993–997, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. C. B. Coulam and B. A. Acacio, “Does immunotherapy for treatment of reproductive failure enhance live births?” American Journal of Reproductive Immunology, vol. 67, no. 4, pp. 296–304, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. K. M. Nyborg, A. M. Kolte, E. C. Larsen, and O. B. Christiansen, “Immunomodulatory treatment with intravenous immunoglobulin and prednisone in patients with recurrent miscarriage and implantation failure after in vitro fertilization/intracytoplasmic sperm injection,” Fertility and Sterility, vol. 102, no. 6, pp. 1650–1655.e1, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. C. M. Boomsma, S. D. Keay, and N. S. Macklon, “Peri-implantation glucocorticoid administration for assisted reproductive technology cycles,” The Cochrane Database of Systematic Reviews, vol. 13, no. 6, Article ID CD005996, 2012. View at Google Scholar · View at Scopus
  10. D. A. Clark, C. B. Coulam, and R. B. Stricker, “Is intravenous immunoglobulins (IVIG) efficacious in early pregnancy failure? A critical review and meta-analysis for patients who fail in vitro fertilization and embryo transfer (IVF),” Journal of Assisted Reproduction and Genetics, vol. 23, no. 1, pp. 1–13, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Dubinskaya, N. Lapteva, and Y. Lukyanova, “The use of plasmapheresis in treatment of patients with infertility, peritoneal endometriosis and NAT2 gene polymorphism,” EUREKA: Health Sciences, vol. 2, pp. 3–10, 2016. View at Publisher · View at Google Scholar
  12. C. Fox, S. Morin, J. Jeong, R. T. Scott, and B. A. Lessey, “Local and systemic factors and implantation: what is the evidence?” Fertility and Sterility, vol. 105, no. 4, pp. 873–884, 2016. View at Publisher · View at Google Scholar
  13. V. Nagendran, N. Emmanuel, and A. S. Bansal, “Does the maternal serum IgG level during pregnancy in primary antibody deficiency influence the IgG level in the newborn?” Case Reports in Immunology, vol. 2015, Article ID 286380, 4 pages, 2015. View at Publisher · View at Google Scholar
  14. R. Z. Sokol, R. D. McClure, M. Peterson, and R. S. Swerdloff, “Gonadotropin therapy failure secondary to human chorionic gonadotropin-induced antibodies,” The Journal of Clinical Endocrinology and Metabolism, vol. 52, no. 5, pp. 929–933, 1981. View at Publisher · View at Google Scholar · View at Scopus
  15. J. P. Hearn, A. A. Gidley-Baird, J. K. Hodges, P. M. Summers, and G. E. Webley, “Embryonic signals during the peri-implantation period in primates,” Journal of Reproduction and Fertility. Supplement, vol. 36, pp. 49–58, 1988. View at Google Scholar · View at Scopus
  16. J. P. Hearn, “Immunological interference with the maternal recognition of pregnancy in primates,” Ciba Foundation Symposium, vol. 64, pp. 353–375, 1978. View at Google Scholar